Showing results (311-320 of 358) with videos related to
Sort By:
Pageof 36
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsGabriela Raquel Paz Rivas, Barbara Loeblein Uebel, Victória Tizeli Souza, et al.Molecular Psychiatry|December 8, 2022
Genetic risk for attention-deficit/hyperactivity disorder predicts cognitive decline and development of Alzheimer's disease pathophysiology in cognitively unimpaired older adultsDouglas T Leffa, João Pedro Ferrari-Souza, Bruna Bellaver, et al.Neurobiology of Aging|September 26, 2024
Modeling the progression of neuropsychiatric symptoms in Alzheimer's disease with PET-based Braak stagingArthur C Macedo, Joseph Therriault, Cécile Tissot, et al.Neurology|December 23, 2024
Comparison of Plasma p-tau217 and [18F]FDG-PET for Identifying Alzheimer Disease in People With Early-Onset or Atypical DementiaKely Monica Quispialaya, Joseph Therriault, Antonio Aliaga, et al.Journal of Neurochemistry|July 21, 2025
Embracing the Modern Biochemistry of Brain MetabolismJuan P Bolaños, Cristina M Alberini, Angeles Almeida, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumPamela C L Ferreira, Guilherme Povala, Bruna Bellaver, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumCristiano Aguzzoli, Guilherme Povala, Pamela C L Ferreira, et al.European Journal of Neurology|October 24, 2024
Plasma phosphorylated tau181 outperforms [18F] fluorodeoxyglucose positron emission tomography in the identification of early Alzheimer diseaseKely Monica Quispialaya, Joseph Therriault, Antonio Aliaga, et al.Brain Communications|March 14, 2024
Predicting functional decline in aging and Alzheimer's disease with PET-based Braak stagingArthur C Macedo, Joseph Therriault, Cécile Tissot, et al.JAMA Neurology|October 18, 2021
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease ContinuumAndréa L Benedet, Marta Milà-Alomà, Agathe Vrillon, et al.Pageof 36